Results 131 to 140 of about 147,468 (308)

NAFLD and NAFLD Related HCC: Emerging Treatments and Clinical Trials

International Journal of Molecular Sciences
Nonalcoholic fatty liver disease (NAFLD), recently renamed metabolic-associated fatty liver disease (MAFLD), is the most prevalent liver disease worldwide. It is associated with an increased risk of developing hepatocellular carcinoma (HCC) in the background of cirrhosis or without cirrhosis.
Tripti Khare, Karina Liu, Lindiwe Oslee Chilambe, Sharad Khare   +3 more
openaire   +2 more sources

The Impact of Sira Vedha (Phlebotomy) at the Right Elbow Joint in the Treatment of Non-Alcoholic Fatty Liver Disease - A Research Report

Journal of Pharmacy and Bioallied Sciences
Non-alcoholic fatty liver disease (NAFLD) affects 9%–53% of the Indian population. No Indian studies have examined Sira Vedha (phlebotomy) for NAFLD, although it has been studied for other conditions.
Gaurav Sawarkar, Punam Sawarkar
doaj   +1 more source

COMPARISON OF SERUM FERRITIN LEVELS IN NAFLD PATIENTS AND HEALTHY CONTROLS

Pakistan Armed Forces Medical Journal, 2020
Objective: To determine and compare serum ferritin levels in non-alcoholic fatty liver disease (NAFLD) patients of our ethnicity. Study Design: Cross sectional comparative study.
Mehwish Qamar, Syeda Abeer Fatima, Haseeb Ahmed Khan, Qudsia Umaira Khan, Amna Nadeem, Hina Sikandar   +5 more
doaj  

Correlation of Serum Transaminase Levels with Liver Fibrosis Assessed by Transient Elastography in Vietnamese Patients with Nonalcoholic Fatty Liver Disease

International Journal of General Medicine, 2021
Vo Duy Thong,1,2 Bui Thi Huong Quynh3 1Department of Internal Medicine, Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam; 2Department of Gastroenterology, Cho Ray Hospital, Ho Chi Minh City, Vietnam;
Thong VD, Quynh BTH
doaj  

Interleukin-17 and myeloperoxidase levels in patients with non-alcoholic fatty liver disease and effect of disease severity on blood counts and liver enzymes

Khyber Medical University Journal
Objectives: To compare the circulating levels of interleukin-17 (IL-17) and myeloperoxidase (MPO) in non-alcoholic fatty liver disease (NAFLD) patients and healthy controls, and to assess the impact of disease severity on blood counts and liver enzyme ...
Mamoona Nazir, Ahmer Ijaz, Nayab Imtiaz, Muhammad Yasir Khan, Gulab Fatima Rani   +4 more
doaj   +1 more source

Study of Prevalence of Non-Alcoholic Fatty Liver Disease in Hypothyroidism and Possible Association of Hypothyroidism with NAFLD Fibrosis Score in Odisha

JK Science
Introduction: Hypothyroidism is being increasingly recognized as a risk factor for developing non-alcoholic fatty liver disease (NAFLD). This study was planned to study the prevalence and evaluate any possible association between hypothyroidism and ...
Siba Prasad Dalai, Sandeep Kumar Ratha, Brijeshraj Swain   +2 more
doaj  

Vitamin D to reduce liver fibrosis in non-alcoholic fatty liver disease [PDF]

, 2017
BACKGROUND: As the prevalence of metabolic risk factors in the American population has increased over time, so too has the diagnoses of non-alcoholic fatty liver disease (NAFLD).
Fox, Ryan
core  

NAFLD: The evolving landscape [PDF]

Journal of Hepatology, 2018
Jacob, George, Quentin, Anstee, Vlad, Ratziu, Arun, Sanyal   +3 more
openaire   +2 more sources

Insights Into Non-Alcoholic Fatty Liver Disease and Diabetes Mellitus in Somalia: Prevalence and Risk Factors

Diabetes, Metabolic Syndrome and Obesity
Mohamed Osman Omar Jeele,1 Hawa Nuradin Mohamed,1 Rukia Omar Barei Addow,2 Mohamed Omar Hassan,3 Bakar Ali Adam4 1Department of Internal Medicine, Mogadishu Somali Turkish Training and Research Hospital, Mogadishu, Somalia; 2Department of Public Health ...
Jeele MOO, Mohamed HN, Addow ROB, Hassan MO, Adam BA   +4 more
doaj  

Probiotics‐derived postbiotics improve host metabolic syndrome by activating the adipocyte thermogenic signaling pathway in high‐fat diet‐fed mice

iMetaOmics, EarlyView.
This schematic illustrates how probiotics‐derived postbiotics (PLBK®1–5) combat high‐fat diet‐induced obesity. Postbiotics remodel gut microbiota, boosting beneficial metabolites. These metabolites activate adipocyte thermogenesis (Ucp1/AMPK pathway), resulting in reduced body weight, improved insulin sensitivity, and alleviated hepatic steatosis in ...
Ye Tian, Liujing Huang, Yifan Liu, Xudong Mai, Yanbo Cheng, Bingdong Liu, Yixin Chen, Liwei Xie   +7 more
wiley   +1 more source